Shopping Cart
Remove All
Your shopping cart is currently empty
Relatlimab (Synonyms: BMS-986016)
Catalog No. T9901A-001 Copy Product Info
🥰Excellent
Relatlimab(BMS-986016) is a monoclonal antibody targeting human anti-LAG-3, generated by immunization of transgenic mice with human immunoglobulin carrying recombinant LAG-3 protein.Relatlimab has a blocking effect, blocking the interaction of LAG-3/MHC II (IC50: 0.67 nM) and LAG-3/FGL1 (IC50: 0.019 nM). Relatlimab is often used with Nivoluma to treat advanced melanoma.
Relatlimab
Copy Product Info🥰Excellent
Catalog No. T9901A-001
Synonyms BMS-986016
Relatlimab(BMS-986016) is a monoclonal antibody targeting human anti-LAG-3, generated by immunization of transgenic mice with human immunoglobulin carrying recombinant LAG-3 protein.Relatlimab has a blocking effect, blocking the interaction of LAG-3/MHC II (IC50: 0.67 nM) and LAG-3/FGL1 (IC50: 0.019 nM). Relatlimab is often used with Nivoluma to treat advanced melanoma.
Cas No. 1673516-98-7
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $166 | - | In Stock | |
| 5 mg | $535 | - | In Stock | |
| 10 mg | $872 | - | In Stock |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:96.8% (SDS-PAGE); 97.2% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Relatlimab(BMS-986016) is a monoclonal antibody targeting human anti-LAG-3, generated by immunization of transgenic mice with human immunoglobulin carrying recombinant LAG-3 protein.Relatlimab has a blocking effect, blocking the interaction of LAG-3/MHC II (IC50: 0.67 nM) and LAG-3/FGL1 (IC50: 0.019 nM). Relatlimab is often used with Nivoluma to treat advanced melanoma. |
| In vitro | Relatlimab (0.001-100 nM) recognizes native LAG-3 and binds to primary activated human and macaque CD4+ T cells with EC50 values of 0.11 nM and 29.11 nM, respectively.[1] Relatlimab (0.001-10000 nM; 3A9-hLAG-3) enhances peptide reactivity of T-cell hybridoma 3A9-hLAG-3 and reverses lag-3-mediated inhibition of T-cell hybridoma 3A9-hLAG-3 Effect, IC50 value is 1.05 nM.[1] Relatlimab (0.001-10000 nM; primary T cells) enhances activation and enhances IL-2 secretion in superantigen-stimulated human PBMC cultures.[1] |
| Synonyms | BMS-986016 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | LAG3/CD223 |
| Molecular Weight | 145.2 kDa |
| Cas No. | 1673516-98-7 |
| Relative Density. | no data available |
| Isotype | Human IgG4 kappa |
| Recommended Isotype Control |
| Storage | -20°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Citations
Calculator
Keywords
Preview
Related Tags: buy Relatlimab | purchase Relatlimab | Relatlimab cost | order Relatlimab | Relatlimab chemical structure | Relatlimab in vitro | Relatlimab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.